NEW YORK--(BUSINESS WIRE)--Sep 6, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the third quarter of 2018 on Thursday, October 25, 2018. During a conference call at 10:30 a.m. EDT on October 25, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 866-548-4713 or international 323-794-2093, confirmation code: 3801700. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:45 p.m. EDT on October 25 through 1:45 p.m. EDT on November 8, 2018. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 3801700.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at  BMS.com  or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005021/en/

CONTACT: Bristol-Myers Squibb Company

Media:

Lisa McCormick Lavery, 609-252-7602

lisa.mccormicklavery@bms.com

or

Investors:

John Elicker, 609-252-4611

john.elicker@bms.com

or

Tim Power, 609-252-7509

timothy.power@bms.com

or

Bill Szablewski, 609-252-5894

william.szablewski@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES BANKING FINANCE RESEARCH OTHER SCIENCE SCIENCE

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2018.

PUB: 09/06/2018 06:59 AM/DISC: 09/06/2018 06:59 AM

http://www.businesswire.com/news/home/20180906005021/en